A Spanish pharmaceuticals maker, Faes Farma has a direct presence in 16 countries, a joint venture in China, and agreements with more than 40 licensees. Iker Etxezarreta Fraile joined as CFO last July after stints as director, Equity Capital & Financial Planning at telecom provider Téléfonica, and vice president, Corporate Treasury at medical equipment manufacturer Werfen. Global Finance: What have been your main priorities at Faes Farma thus far? Iker Etxezarreta: One of my main priorities has